Pharvaris N.V. (PHVS) Insider Trading
Over the last 3 months, PHVS insiders made 0 open-market buys and 18 sales, a net sale of -$5.5M (SEC Form 4). Over the last 6 months, 84 institutions increased and 70 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
18
Net (3m)
-$5.5M
Insider trades by month Buys Sells
Apr
May
Jun
Jul
Aug
Context3-month price +19%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Modig Berndtdirector, officer: Chief Executive Officer | Sell | 2,292 | $34.77 |
| Aug 13, 2026 | Lu Pengofficer: President | Tax | 109 | $34.84 |
| Aug 13, 2026 | Lu Pengofficer: President | Tax | 117 | $34.42 |
| Jul 15, 2026 | Modig Berndtdirector, officer: Chief Executive Officer | Sell | 2,292 | $34.97 |
| Jul 14, 2026 | Lu Pengofficer: Chief Medical Officer | Tax | 117 | $35.07 |
| Jul 14, 2026 | Lu Pengofficer: Chief Medical Officer | Tax | 109 | $35.07 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 8,300 | $35.05 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 2,300 | $35.12 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Option | 4,200 | $8.05 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Option | 4,100 | $2.59 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Option | 900 | $8.05 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Option | 1,400 | $2.59 |
| Jul 1, 2026 | Schikan Johannes Gerardus Christiaan Petrusdirector | Sell | 6,888 | $35.05 |
| Jul 1, 2026 | Schikan Johannes Gerardus Christiaan Petrusdirector | Sell | 30,712 | $35.49 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 30,703 | $35.49 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 6,997 | $35.05 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 27,872 | $35.48 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Option | 24,900 | $8.05 |
| Jul 1, 2026 | Lesage Anneofficer: Chief Early Development | Option | 2,972 | $2.59 |
| Jun 29, 2026 | Lesage Anneofficer: Chief Early Development | Option | 900 | $8.05 |
| Jun 29, 2026 | Lu Pengofficer: Chief Medical Officer | Sell | 14,700 | $34.00 |
| Jun 29, 2026 | Lu Pengofficer: Chief Medical Officer | Option | 14,700 | $2.59 |
| Jun 29, 2026 | Lu Pengofficer: Chief Medical Officer | Sell | 3,400 | $35.09 |
| Jun 29, 2026 | Lu Pengofficer: Chief Medical Officer | Sell | 11,600 | $34.45 |
| Jun 29, 2026 | Lu Pengofficer: Chief Medical Officer | Option | 15,000 | $2.59 |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan Petrusdirector | Sell | 2,400 | $35.10 |
| Jun 29, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 2,300 | $35.12 |
| Jun 29, 2026 | Lesage Anneofficer: Chief Early Development | Option | 1,400 | $2.59 |
| Jun 23, 2026 | Lu Pengofficer: Chief Medical Officer | Sell | 300 | $34.00 |
| Jun 23, 2026 | Lu Pengofficer: Chief Medical Officer | Option | 300 | $2.59 |
Source: PHVS SEC Form 4 filings, latest Aug 18, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their PHVS positions over the last 6 months (SEC Form 13F).
Increased
84
New positions
35
Reduced
70
Sold out
9
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| GENERAL ATLANTIC, L.P. | Unchanged | 8.0M | May 15, 2026 |
| FMR LLC | Increased | 6.6M | Aug 13, 2026 |
| GENERAL ATLANTIC, L.P. | Reduced | 6.6M | Aug 14, 2026 |
| FMR LLC | Reduced | 6.3M | May 15, 2026 |
| FORESITE CAPITAL MANAGEMENT IV, LLC | Unchanged | 4.8M | May 15, 2026 |
| Foresite Capital Management IV, LLC | Unchanged | 4.8M | Aug 14, 2026 |
| venBio Partners LLC | Increased | 4.6M | Aug 14, 2026 |
| VENBIO PARTNERS LLC | Unchanged | 4.6M | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 3.7M | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 3.7M | Aug 14, 2026 |
| EQT Fund Management S.a r.l. | Unchanged | 3.4M | Aug 13, 2026 |
| EQT FUND MANAGEMENT S.A R.L. | Unchanged | 3.4M | May 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Increased | 3.4M | Aug 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 3.1M | May 15, 2026 |
| Bain Capital Life Sciences Investors, LLC | Unchanged | 2.7M | Aug 14, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.